Literature DB >> 16750912

On the preparation, microscopic investigation and application of ISCOMs.

Julia Myschik1, Dirk G Lendemans, Warren T McBurney, Patrick H Demana, Sarah Hook, Thomas Rades.   

Abstract

ISCOM matrices constitute colloidal structures formed from Quillaja saponins, cholesterol and phospholipid. Addition of protein antigens to these matrices leads to the formation of ISCOMs. In this review we report on microscopic investigations of ISCOM matrices and ISCOMs as well as related colloidal structures, such as helices, worm-like micelles, ring-like micelles, and lamellae structures. We briefly outline the immunologic basis for the use of ISCOMs as vaccine delivery systems, and describe the various methods to form ISCOMs. Negative staining transmission electron micrographs of all colloidal structures are presented and described. On the basis of our microscopic investigations, different formation mechanisms of ISCOMS are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750912     DOI: 10.1016/j.micron.2006.03.016

Source DB:  PubMed          Journal:  Micron        ISSN: 0968-4328            Impact factor:   2.251


  9 in total

1.  In vitro cutaneous application of ISCOMs on human skin enhances delivery of hydrophobic model compounds through the stratum corneum.

Authors:  Henriette Baun Madsen; Peter Ifversen; Flemming Madsen; Birger Brodin; Ingrid Hausser; Hanne Mørck Nielsen
Journal:  AAPS J       Date:  2009-10-28       Impact factor: 4.009

Review 2.  Defensins as anti-inflammatory compounds and mucosal adjuvants.

Authors:  Karl G Kohlgraf; Lindsey C Pingel; Deborah E Dietrich; Kim A Brogden
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

3.  Structure of immune stimulating complex matrices and immune stimulating complexes in suspension determined by small-angle x-ray scattering.

Authors:  Jan Skov Pedersen; Cristiano L P Oliveira; Henriette Baun Hübschmann; Lise Arleth; Søren Manniche; Nicolai Kirkby; Hanne Mørck Nielsen
Journal:  Biophys J       Date:  2012-05-15       Impact factor: 4.033

4.  Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants.

Authors:  Mariana Rivera-Patron; Samuel P Cibulski; Iris Miraballes; Fernando Silveira
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Advances in Infectious Disease Vaccine Adjuvants.

Authors:  Jingyi Fan; Shengbin Jin; Lachlan Gilmartin; Istvan Toth; Waleed M Hussein; Rachel J Stephenson
Journal:  Vaccines (Basel)       Date:  2022-07-13

6.  Functionalization of immunostimulating complexes (ISCOMs) with lipid vinyl sulfones and their application in immunological techniques and therapy.

Authors:  Teresa Cruz-Bustos; Gloria González-González; Julia Morales-Sanfrutos; Alicia Megía-Fernández; Francisco Santoyo-González; Antonio Osuna
Journal:  Int J Nanomedicine       Date:  2012-12-03

7.  Tubular immunostimulating complex based on cucumarioside A2-2 and monogalactosyldiacylglycerol from marine macrophytes.

Authors:  Eduard Y Kostetsky; Nina M Sanina; Andrey N Mazeika; Alexander V Tsybulsky; Natalia S Vorobyeva; Valery L Shnyrov
Journal:  J Nanobiotechnology       Date:  2011-09-02       Impact factor: 10.435

8.  Synthesis, Formulation, and Adjuvanticity of Monodesmosidic Saponins with Olenanolic Acid, Hederagenin and Gypsogenin Aglycones, and some C-28 Ester Derivatives.

Authors:  Ben W Greatrex; Alison M Daines; Sarah Hook; Dirk H Lenz; Warren McBurney; Thomas Rades; Phillip M Rendle
Journal:  ChemistryOpen       Date:  2015-09-30       Impact factor: 2.911

9.  Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells.

Authors:  Fernando Rodríguez-Serrano; Nuria Mut-Salud; Teresa Cruz-Bustos; Mercedes Gomez-Samblas; Esther Carrasco; Jose Manuel Garrido; F Javier López-Jaramillo; Francisco Santoyo-Gonzalez; Antonio Osuna
Journal:  Int J Nanomedicine       Date:  2016-09-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.